The Manila Times

First licensed treatment now available for condition behind the UK’s leading cause of horse euthanasia

New veterinary treatment targets insulin dysregulation, the most common cause of laminitis in horses and ponies ...

Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III L…

RAMAT GAN, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- (NYSE American: CANF) (TASE: CANF), a biotechnology company developing ...
Diabetes.co.uk

NHS study links app use to weight loss and improved psoriatic arthritis outcomes

New research published in BMC Rheumatology has found that people with psoriatic arthritis who regularly used the Gro Health ...
quiverquant

Can-Fite BioPharma Reports H1 2026 Clinical Progress and Financial Results, Including Promising Survival Data in Pancreatic and Liver Cancer Studies

Can-Fite BioPharma reports clinical progress in cancer and psoriasis therapies, alongside H1 2026 financial outcomes.